During the corresponding time, China Pharma Holdings Inc saw a revenue deteriorated by -7.55 % year on year, sequentially revenue fell by -3.58 %. While revenue at the China Pharma Holdings Inc's corporate clients
China Pharma Holdings Inc's Comment on Sales, Marketing and Customers
The company operates in China’s healthcare market, manufacturing off-patent branded generic drugs for conditions with high incidence and mortality rates, including cardiovascular, central nervous system, infectious, and digestive diseases. Following the COVID-19 outbreak, it introduced epidemic prevention products such as medical masks, surgical masks, KN95 masks, N95 masks, and wash-free sanitizers. The company also develops products in the broader healthcare sector, including Noni enzymes. Its product development focuses on generic and innovative drugs for chronic diseases common in China, including geriatric diseases, cancers, and nutritional products. Additionally, the company plans to create digital interactive healthcare solutions to improve user experience and patient satisfaction. Sales and marketing efforts target hospital physicians to promote existing brands, increase national recognition, and maintain branded pricing.
China Pharma Holdings Inc’s Comment on Sales, Marketing and Customers
The company operates in China’s healthcare market, manufacturing off-patent branded generic drugs for conditions with high incidence and mortality rates, including cardiovascular, central nervous system, infectious, and digestive diseases. Following the COVID-19 outbreak, it introduced epidemic prevention products such as medical masks, surgical masks, KN95 masks, N95 masks, and wash-free sanitizers. The company also develops products in the broader healthcare sector, including Noni enzymes. Its product development focuses on generic and innovative drugs for chronic diseases common in China, including geriatric diseases, cancers, and nutritional products. Additionally, the company plans to create digital interactive healthcare solutions to improve user experience and patient satisfaction. Sales and marketing efforts target hospital physicians to promote existing brands, increase national recognition, and maintain branded pricing.
Sources:
China Pharma Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: China Pharma Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on China Pharma Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
